NextCure, Inc. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6aa1ba3c-ef3a-4b77-b807-9d6326f5d1c0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-55.8M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-024137 |
| FY 2024 | $-55.7M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-002402 |
| FY 2023 | $-62.7M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-003672 |
| FY 2022 | $-74.7M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-002698 |
| FY 2021 | $-69.4M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002824 |
| FY 2020 | $-36.6M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002384 |
| FY 2019 | $-33.7M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002566 |
| FY 2018 | $-22.8M | 2018-01-01 – 2018-12-31 | evidence 0001558370-20-002566 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).